1 |
王文松,钱美华,王曼玲, 等. 急性白血病下呼吸道感染特点及危险因素分析[J]. 中华医院感染学杂志,2013,23(6):1290-1293.
|
2 |
中华人民共和国卫生部. 医院感染诊断标准(试行) [J]. 中华医学杂志,2001,81(5):314-320.
|
3 |
叶应妩,王毓三主编. 全国临床检验操作规程[M]. 3版. 南京: 东南大学出版社,2006:736-753.
|
4 |
肖喜春,司金春,陈淑霞, 等. 老年急性髓系白血病患者化疗期间医院感染的危险因素及防治[J/CD]. 中华实验和临床感染病杂志:电子版,2014,8(5):631-634.
|
5 |
王文松,钱美华,王曼玲, 等. 急性白血病下呼吸道感染特点及危险因素分析[J]. 中华医院感染学杂志,2013,23(6):1290-1293.
|
6 |
梁利杰,梁华杰,孙慧. 急性白血病患者化疗后感染的临床分析[J]. 中华医院感染学杂志,2014,24(15):3744-3746.
|
7 |
许洪志,仲春红,徐功立, 等. 急性白血病医院感染及其危险因素的研究[J]. 中华医院感染学杂志,2010,15 (1):37-41.
|
8 |
陈映,乔岩,赵燕, 等. 医院感染细菌的临床分布及耐药性分析[J/CD]. 中华实验和临床感染病杂志:电子版,2013,7(1):91-95.
|
9 |
尹小英,余凤华. 白血病患者化疗期感染预防与护理[J]. 中国实用医药,2011,46(1):154-156.
|
10 |
林斌,吴国才,李庆华, 等. 急性白血病患者红细胞免疫粘附功能的研究[J]. 中国基层医药,2007,14(4):549-550.
|
11 |
吴军,刘泽,张源源, 等. 长期卧床高龄患者医院内感染前后血浆白蛋白水平及细胞免疫功能的变化[J]. 中华老年多器官疾病杂志,2013,12(9):643-645.
|
12 |
王增胜,王晓敏. 伊达比星与柔红霉素联合阿糖胞苷方案诱导初治急性髓系白血病患者疗效分析[J]. 中国医师进修杂志,2014,37(19):66-68.
|
13 |
Pereira CA, Marra AR, Camargo LF, et al. Nosocomial blood-stream infections in Brazilian pediatric patients: microbiology, epidemiology, and clinical features[J]. PLoS One,2013,8(7):e68144.
|
14 |
Rhee Y, Heung M, Chen B, et al. Central line-associated blood-stream infections in non-ICU inpatient wards:a 2-year analysis[J]. Infect Control Hosp Epidemiol,2015,36(4):424-430.
|
15 |
Kugler E, Levi A, Goldberg E, et al. The association of central venous catheter placement timing with infection rates in patients with acute leukemia[J]. Leuk Res,2015,39(3):311-313.
|
16 |
Merrill KC, Sumner S, Linford L, et al. Impact of universal disinfectant cap implementation on central line-associated blood-stream infections[J]. Am J Infect Control,2014,42(12):1274-1277.
|
17 |
于海涛,胡智军. 白血病肺部感染CT诊断附96例分析[J]. 中国临床实践杂志,2006,17(5):40-42.
|
18 |
des Champs-Bro B, Leroy-Cotteau A, Mazingue F, et al. Invasive fungal infections:epidemiology and analysis of antifungal prescriptions in onco-haematology[J]. J Clin Pharm Ther,2011,36(2):152-160.
|
19 |
Kurosawa M, Yonezumi M, Hashino S, et al. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies[J]. Int J Hematol,2012,96(6):748-757.
|
20 |
Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies:the SEIFEM-2004 study[J]. Haematologica,2006,91(8):1068-1075.
|
21 |
Herbrecht R, Caillot D, Cordonnier C, et al. Indications and outcomes of antifungal therapy in French patients with haematologieal conditions or recipients of haematopoietic stem cell transplantation[J]. J Antimicrob Chemother,2012,67(11):2731-2738.
|
22 |
Hahn-Ast C, Glasmacher A, Muckter S, et al. Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006[J]. J Antimicrob Chemother,2010,65:761-768.
|
23 |
Sun Y, Huang H, Chen J, et al. Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter,prospective,observational study in China[EB/OL]. Tumour Biol,2014.
URL
|
24 |
孙雪峰,韩冰,冯俊, 等. 恶性血液病继发侵袭性肺部真菌感染的临床特点[J]. 中国医学科学院学报,2009,31(5):575-579.
|
25 |
Nobuyuki T, Tsuneo M, Gouji M, et al. HRCT findings of chest complications in patients with leukemia[J]. Eur Radiol,2002,12(10):1512-1522.
|